Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

This study has been terminated.

( Based on Independent Data Monitoring Committee (IDMC) recommendation. )

Study NCT00688766 Information provided by Infinity Pharmaceuticals, Inc.

First Received: May 29, 2008 Last Updated: January 2, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2009
Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)